BioCentury | May 23, 2005
Company News
Inhibetex, Organic Soils.com Inc. deal
...Cancer company Inhibetex reverse merged with OSLC in a stock deal. Inhibetex shareholders will own about...
...be named Inhibiton Therapeutics Inc. Inhibiton is studying how PKC isozymes regulate brain cancer cells. Inhibetex Therapeutics Inc....
...be named Inhibiton Therapeutics Inc. Inhibiton is studying how PKC isozymes regulate brain cancer cells. Inhibetex Therapeutics Inc....
